Cellular distribution of human tissue kallikreins: immunohistochemical localization

Constantina D Petraki1, Panagiotis A Papanastasiou, Vassiliki N Karavana

  • 1Department of Pathology, Evangelismos Hospital, GR-10676 Athens, Greece, and Depament of Laboratory Medicine and Pathobiology, University of Toronto, Canada.

Biological Chemistry
|June 28, 2006
PubMed

Insights

This study examined human kallikreins (hKs) in normal and malignant tissues, finding they are widely expressed and secreted, suggesting common regulation. Most hKs were detected in adenocarcinomas, with potential prognostic value explored in various cancers.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Proteomics

Background:

  • Human kallikreins (hKs) are a large family of serine proteases with diverse functions.
  • Understanding the expression patterns of hKs is crucial for elucidating their roles in normal physiology and disease.

Purpose of the Study:

  • To investigate the immunohistochemical expression (IE) of eight non-tissue-specific human kallikreins (hK5, 6, 7, 10, 11, 12, 13, and 14) in normal and malignant human tissues.
  • To compare the expression patterns of these hKs across different tissues and explore their potential tissue specificity.
  • To evaluate the expression of hKs in various carcinomas and assess their prognostic value.

Main Methods:

  • Immunohistochemistry (IE) was employed to detect the expression of eight non-tissue-specific hKs in normal and malignant tissues.
  • Results were correlated with existing data from RT-PCR and ELISA assays.
  • Prognostic value was assessed in series of prostate, renal cell, colon, and urothelial carcinomas.

Main Results:

  • The IE of the studied hKs was consistently cytoplasmic and showed characteristic patterns in certain tissues.
  • No major differences in IE were observed among the studied hKs across different tissues, suggesting a common regulatory mechanism.
  • hKs were detected in a variety of tissues, with glandular epithelia and their secretions being primary sites, indicating secretion.
  • Tumors derived from tissues expressing kallikreins tested positive, with most hKs expressed in adenocarcinomas.

Conclusions:

  • Non-tissue-specific human kallikreins are widely expressed and secreted in various normal tissues, indicating a shared regulatory pathway.
  • The expression of these hKs in adenocarcinomas suggests their involvement in cancer development.
  • Further investigation into the prognostic value of specific hKs in different cancer types is warranted.